1.
|
|
2.
|
Different therapeutic nucleic acids (TNAs) can be unified in a single structure by their elongation with short oligonucleotides designed to self-assemble into nucleic aci[...]
2022 | articles |
|
3.
|
Nucleic acid nanoparticles (NANPs) require a carrier to allow for their intracellular delivery to immune cells. Cytokine production, specifically type I and III interfero[...]
2023 | articles |
|
4.
|
Besides being a passive carrier of genetic information, DNA can also serve as an architecture template for the synthesis of novel fluorescent nanomaterials that are arran[...]
2019 | articles |
|
5.
|
|
6.
|
RNA aptamers selected to bind fluorophores and activate their fluorescence offer a simple and modular way to visualize native RNAs in cells. Split aptamers which are inac[...]
2018 | articles |
|
7.
|
Infusion reactions (IRs) create a translational hurdle for many novel therapeutics, including those utilizing nanotechnology. Nucleic acid nanoparticles (NANPs) are a nov[...]
2019 | articles |
|
8.
|
RNAi-based technologies have shown biomedical potential; however, safe and efficient delivery of RNA remains a barrier for their broader clinical applications. Nucleic ac[...]
2020 | articles |
|
9.
|
Small interfering RNAs (siRNAs) are potential therapeutic substances due to their gene silencing capability as exemplified by the recent approval by the US Food and Drug [...]
2020 | articles |
|
10.
|
In 2015, the J. Murrey Atkins Library recruited faculty, staff, alumni, and students to submit digital images of photomicrographic art, which were printed and placed on e[...]
2017 | articles |
|